This inventor holds 1 USPTO granted patent. Top assignee: Intervet Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations of Jonathan Simmons
Introduction
Jonathan Simmons is an accomplished inventor based in Ware, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating JAK-mediated diseases.
Latest Patents
Simmons holds a patent for a compound titled "Crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide." This patent relates to the crystalline forms of the compound and the processes for its preparation. The compound is particularly useful for the treatment of conditions such as atopic dermatitis.
Career Highlights
Jonathan Simmons has been associated with Intervet Inc., where he has utilized his expertise in pharmaceutical innovations. His work has contributed to advancements in medical treatments and has the potential to improve the quality of life for patients suffering from various conditions.
Collaborations
Simmons has collaborated with notable colleagues, including Christophe Pierre Alain Chassaing and Xiaoling Jin. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Jonathan Simmons exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for medical conditions.